Saw Pipes Q4 results on July 30, 2001

A meeting of the Board of Directors of Saw Pipes Ltd is scheduled to be held on July 30, 2001 to take on record the Estimated Unaudited Financial Results for the quarter ended June 30, 2001 of the Company.

Kochi Refineries Q1 results on July 25, 2001

A meeting of the Board of Directors of Kochi Refineries Ltd is scheduled to be held on July 25, 2001 for taking on record the Unaudited Financial Results for the Quarter ended June 30, 2001.

Hinduja Finance Q1 results on July 26, 2001

A meeting of the Board of Directors of Hinduja Finance Corporation Ltd is scheduled to be held on July 26, 2001 to consider the Unaudited Financial Results of the Company for the quarter ended June 30, 2001.

Smithkline Beecham Pharma Q2 results on July 27, 2001

A meeting of the Board of Directors of Smithkline Beecham Phamaceuticals (I) Ltd is scheduled to be held on July 27, 2001 to consider amongst other things, approval of unaudited financial results for the quarter ended June 30, 2001.

Ranbaxy anti-AIDS drug gets approval from Brazil regulatory authority

Ranbaxy S.P Medicamentos, Brazil, a majority owned Company of Ranbaxy Laboratories Ltd, India, has received approval from the Brazilian Regulatory Authority, ANVS, for its anti-AIDS Drug Lamivudine. This is the first bio-equivalent generic approval in Brazil in anti-AIDS segment. Lamivudine (3TC) is a synthetic neucleoside analog with activity against HIV-1. It is commonly prescribed as a part of HAART (High Active Anti-Retroviral Regimen) in combination with other Anti-Retrovirals,. Lamivudine is a well tolerated NRTI (Nucleuside Analog Reverse Transcriptase Inhibitor) with no drug interactions and has proven efficacy in combination with Zidovudine. It is the only Retroviral to be approved for the treatment of Hepatitis B as well. Ranbaxy expects to launch the generic version of Lamivudine in Brazil by September 2001. The originator product 'Epivir' is from Glaxo Smithkline. The branded medicine costs around R$ 210.55 for 60s and the ministry of Health (MOH) expects that that generic version will cost 40% less (around R$ 126.33). Epivir is the part of the cocktail of medicines distributed free of cost by MOH. The target of MOH is to distribute 22 million of Lamivudine dosages to the HIV infected patients. The MOH is Brazil procures approximately US$ 500 million worth of drugs annually for free distribution and 70% of this is allotted for anti-AIDS products.

GSFC Q1 results postponed to July 27, 2001

Gujarat State Fertilizers & Chemicals Ltd has informed BSE that the meeting of the Board of Directors to consider and approve Unaudited Financial results for the quarter ended June 30, 2001 which was scheduled to be held on July 20, 2001 has been postponed to July 27, 2001.

BPL Q1 results on July 23, 2001

A meeting of the Board of Directors of BPL Ltd is scheduled to be held on July 23, 2001 to consider and take on record the Un-audited Financial Results for the first quarter ended June 30, 2001

All resolution passed unanimously by shareholders at Silverline's AGM

Silverline Technologies Ltd (SLT) has announced that its annual General Meeting in Mumbai, India was held as scheduled on July 9, 2001 wherein all resolutions have been passed unanimously by the shareholders, including approval of the annual dividend on the Silverline equity shares for the fiscal year ended March 31, 2001. Silverline shareholders approved a full year dividend of Rs 1.25 approximately US$ 0.0265, per share, or Rs 2.50, approximately US$0.053, per ADS. One Silverline ADS represents two Silverline equity shares. The holders of record of SLTpr ADSs issued at the completion of the merger of Silverline with SeraNova, Inc on March 7, 2001, will be eligible for the full year dividend of approximately US$0.053. Holders of record of STL ADSs issued on June 20, 2000 in connection with Silverline's initial public offering in the US will be entitled to a pro rated dividend (from June 20, 2000 to March 31, 2001) of approximately $0.0408. The exact dollar amount of the US dividend will be dependent upon the rupee to US dollar exchange rate at the time of dividend distribution. Prior to the July 3, 2001 record date, Silverline was required to use different New York Stock Exchange ticker symbols (SLT and SLT.pr) to identify the two different issues of its ADSs. This was to comply with Securities and Exchange Board of India (SEBI) regulatory requirements on the pro rating of annual dividends. The SLTpr ADSs, issued on March 7, 2001, were temporarily not fungible with pre-existing Silverline ADSs (SLT) issued on June 20, 2000. Following the record date, there is no further need to have the two different symbols. Thus, the SLT.pr symbol has expired and SLT remains as the ongoing trading symbol for all Silverline ADSs. The last day for trading in the temporary program (SLT.pr) was July 3, 2001. Shareholders with SLT.pr ADSs will now have the same ADSs reflected under the SLT symbol.

Silverline announces new organisation structure to more effective address market opportunities

Silverline Technologies Ltd today (July 13, 2001) announced the creation of the office of CEO. Ravi Singh has been appointed as co-CEO of the Company. Shankar Iyer, current CEO & President of Silverline, will assume the title of co-CEO of Silverline for the next three months to effect a smooth transition. Shankar will continue to serve on the Board of Directors of the Company. Ravi Subramanian, Chairman, is assuming an Executive Chairman position with intent to be more actively involved in the oversight of the Company's operations. The new appointments are effective immediately. Commenting on these changes, Ravi Subramanian noted, "the market for our services is highly dynamic and global. Over the past nine years, Silverline has grown from a mere business plan to one of the largest and the most global India-based IT Solutions company. Our rapid growth has left us extended on many fronts, and we believe our ability to successfully address the multiple opportunities that the market presents and to better negotiate a tough economic environment, is contingent upon adding further depth to our management team. This management team expansion will allow us to seize opportunities, which in the past we could not fully exploit." The appointment of Ravi Singh as co-CEO comes at a time when industry growth in the US market has faltered as a result of deceleration in the US economy.

Amitabh Jhunjhunwala is the new Additional Director of BSES

BSES Ltd has informed BSE that the Board of Directors of the company has appointed Shri Amitabh Jhunjhunwala, as Additional Director of the company, in place of Shri S.C.Gupta who resigned from the Board with effect from June 28, 2001.

G G Dandekar Machine Works opts for 4-day week

G.G. Dandekar Machine Works Ltd has informed BSE that, due to bad business condition, company will work only four days in a week, i.e. Monday to Thursday. This practice will continue till the end of December 2001. The Company is expected to resume earlier than end December 2001 if the business conditions improve.

Ranbaxy clarifies on news item

With reference to the news article appearing in a leading financial daily titled " Ranbaxy deal under threat" Ranbaxy Laboratories Ltd has informed BSE that the estimated dollar 30 million a year in royalties quoted in the news item is not an estimate of the Company nor the Company has communicated any estimate in this regard. The Company has further clarified that as for Bayer developing a possible alternative to a drug it has licensed from the Company as mentioned in the news item, Bayer has two 500 mg once-a-day dosage products in phase III trials-one from Ranbaxy and the other from a source that the Company does not know about.

Manipal Finance Board approves issue of shares on preferential basis

Manipal Finance Corporation Ltd has informed BSE that the Board of Directors of the company has approved as under: 1. Issue of 1 million Non-cumulative Redeemable Preference Shares of Rs 10 each through private placement. 2. Issue of 1.60 million equity shares of Rs.10 each through preferential allotment basis.

Gujarat Gas H1 results on July 26, 2001

Gujarat Gas Company Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on July 26, 2001 to consider unaudited financial results of the Company for the six months ended June 30, 2001.

Pentamedia Graphics Q1 results on July 23, 2001

A meeting of the Board of Directors of Pentamedia Graphics Ltd is scheduled to be held on July 23, 2001 to consider the quarterly unaudited (provisionals) financial results for the quarter ended June 30, 2001.

Supreme Woollen Mills to allot shares on preferential basis

Supreme Woollen Mills Ltd has informed BSE that the Board of Directors of the company has decided to issue 7 million equity shares of Rs 10 each to Promoters on preferential basis.

Apollo Hospitals Q1 results on July 31, 2001

A meeting of the Board of Directors of Apollo Hospital Enterprise Ltd is scheduled to be held on July 31, 2001 to consider the Unaudited Financial Results of the Company for the quarter ended June 30, 2001.

Swasti Vinayaka Synthetics fixes Record Date for the purpose of Stock Spilt

Swasti Vinayaka Synthetics Ltd has fixed the record date as August 14, 2001 for the purpose of Stock Split of existing equity shares - from every one existing equity share of Rs.10 each into ten equity shares of Re.1 each.

BSE to shift Hindustan Softel from 'Z' to 'B2' Group

BSE has informed the members of the Exchange that Hindustan Softel Ltd will be shifted to B2 Group from Z Group with effect from July 16, 2001

Ravi K Sheth holds 5.007% stake in GE Shipping

G E Shipping Co. Ltd has informed BSE that the Company has received intimation of Mr. Ravi K. Sheth that he individually holds 1,08,11,095 equity shares of Rs 10 each which is 5.007% of the equity capital of the Company. Mr. Ravi K. Shah is one of the promoters of the Company. The Company has also informed that the promoters hold in aggregate 5,53,52,712 equity shares being 21.01% of the equity capital of the Company as on June 30, 2001.

Sesa Goa employees resort to 72-hour illegal strike

Sesa Goa Ltd has informed BSE that the employees of the Company have resorted to a 72-hour illegal strike from July 11, 2001 adversely affecting the normal activities of the Company.

Money

Rapid Information on Stocks & Corporates

Tell us what you think of this report